Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph phase_1
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

terminated133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer

NCT04586686
unknownphase_1

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

NCT04616729
terminated

Comparison of Two Different Sedation Protocols During Transvaginal Oocyte Retrieval

NCT03362021

Clinical Trials (3)

Showing 3 of 3 trials
NCT04586686Not Applicable

Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer

Unknown
NCT04616729Phase 1

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

Unknown
NCT03362021

Comparison of Two Different Sedation Protocols During Transvaginal Oocyte Retrieval

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3